Germany· DE-A57-587112a418b6c32e
Dapson-Fatol
A dapsone product containing dapsone, registered in Germany by Esteve Pharmaceuticals Gmbh. The same ATC class is registered in 10 of our 19 countries.
Checked against EMA Article 57 (European Union) on
Informational only — not a medical device.
Where it is registered
Dapsone is registered in 10 of 19 countries.
Countries holding a registration under ATC J04BA02 (dapsone), each read from that country’s own register.
- This record: Germany, from EMA Article 57 (European Union)
- 4 of them publish a price we can compare per daily dose
Dapsone · ATC J04BA02
10 / 19 countries
- Canada
- Denmark
- Finlandprice
- Germany
- Japan
- Netherlands
- Norwayprice
- Polandprice
- United Kingdom
- United Statesprice
The record
At a glance
EMA Article 57 (European Union)- Active substance
- Dapsone
- Manufacturer
- Esteve Pharmaceuticals Gmbh
- Country
- Germany (DE)
- ATC code
- J04BA02
- ATC class
- Dapsone
- Defined daily dose
- 50 mg, O
- Reimbursed
- Not published by this register
- Source register
- EMA Article 57 (European Union)
- Last checked
- September 30, 2026
Packs & prices · 0
No packs listed by the register for this record.
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Interactions
415 interactions on record for dapsone.
Graded by severity as the source publishes them — 7 severe. Severity grades are free for everyone; mechanism and management come with Growth.
- Severity for every pair — free, no plan needed
- The source, licence and sync date on every record
- Mechanism and what to do for each pair — Growth plan
Dapsone · interactions on record
415 records
- 7 severe
- 206 moderate
- 2 minor
- 200 info
Most severe, free to view
- SaquinavirJ05AE01severe
- CladribineL01BB04severe
- Aminolevulinic acidL01XD04severe
- CladribineL04AA40severe
- Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Same medicine, other countries
Dapsone in 8 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- United StatesAczoneAlmirall, LLC
- United KingdomDapsone 100mg tabletsWaymade Healthcare Plc
- NorwayDapsonScanpharm
- CanadaACZONEBAUSCH HEALTH, CANADA INC.
- PolandDusalmAdamed Pharma S.A.
- NetherlandsDapson Tiofarma 100 mg, tablettenTiofarma B.V.
- SpainSULFONA COMPRIMIDOSEsteve Pharmaceuticals S.A.
- Japanジアフェニルスルホン田辺ファーマ
Authorised across Europe · EMA
The same active substance is authorised in 7 EEA countries. Names it is sold under:
- Denmark · Dapson Scanpharm
- United Kingdom (Northern Ireland) · Dapsone Macleods Pharma Uk, Dapsone Milpharm
- Malta · Dapsone Tillomed Laboratories
- Netherlands · Dapson Tiofarma
- Norway · Dapson Scanpharm
- Poland · Dusalm
- Portugal · Sulfona Zimaia
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of EMA Article 57 (European Union). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/3e7276a3-9dee-4d3c-b2d4-e05ee1428b1c GET /v1/drugs/3e7276a3-9dee-4d3c-b2d4-e05ee1428b1c?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"pzn": null,
"route": "Oral Use",
"source": "ema_art57_de",
"ma_number": null,
"substance": "Dapsone",
"atc_from_source": null,
"authorisation_country": "Germany"
}See everything about dapsone.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.